Reneo Pharmaceuticals

OverviewSuggest Edit

Reneo Pharmaceuticals is a clinical-stage pharmaceutical company focused on the development of therapies for patients with genetic mitochondrial diseases. The Company is currently developing REN001, a PPAR delta agonist, to treat genetically defined rare mitochondrial diseases such as fatty acid oxidation disorders and primary mitochondrial myopathies.

TypePrivate
Founded2018
HQSan Diego, US
Websitereneopharma.com

Latest Updates

Employees (est.) (Mar 2020)14(+17%)

Key People/Management at Reneo Pharmaceuticals

Mike Grey

Mike Grey

Executive Chairman

Reneo Pharmaceuticals Office Locations

Reneo Pharmaceuticals has an office in San Diego
San Diego, US (HQ)
12230 El Camino Real #230
Show all (1)

Reneo Pharmaceuticals Financials and Metrics

Summary Metrics

Founding Date

2018

Reneo Pharmaceuticals total Funding

$50 m

Reneo Pharmaceuticals latest funding size

$50 m

Time since last funding

10 months ago

Reneo Pharmaceuticals investors

Reneo Pharmaceuticals's latest funding round in May 2019 was reported to be $50 m. In total, Reneo Pharmaceuticals has raised $50 m
Show all financial metrics

Reneo Pharmaceuticals Online and Social Media Presence

Embed Graph

Reneo Pharmaceuticals News and Updates

Reneo Pharmaceuticals Announces Presentations at the INFORM Conference in Amsterdam

SAN DIEGO, Aug. 30, 2019 /PRNewswire/ -- Reneo Pharmaceuticals, a clinical stage pharmaceutical company, today announced that Alex Dorenbaum, MD, chief medical officer, will present at the INFORM (International Network for Fatty Acid Oxidation Research and Management) annual conference in...

Reneo Pharmaceuticals Blogs

FDA Grants Orphan Drug Designation to Reneo Pharmaceuticals for REN001 for Treatment of Fatty Acid Oxidation Disorders

The post FDA Grants Orphan Drug Designation to Reneo Pharmaceuticals for REN001 for Treatment of Fatty Acid Oxidation Disorders appeared first on Reneo.

Reneo Pharmaceuticals Frequently Asked Questions

  • When was Reneo Pharmaceuticals founded?

    Reneo Pharmaceuticals was founded in 2018.

  • Who are Reneo Pharmaceuticals key executives?

    Reneo Pharmaceuticals's key executives are Mike Grey.

  • How many employees does Reneo Pharmaceuticals have?

    Reneo Pharmaceuticals has 14 employees.

  • Who are Reneo Pharmaceuticals competitors?

    Competitors of Reneo Pharmaceuticals include Elicio Therapeutics, Stelexis Therapeutics and GeneQuine Biotherapeutics.

  • Where is Reneo Pharmaceuticals headquarters?

    Reneo Pharmaceuticals headquarters is located at 12230 El Camino Real #230, San Diego.

  • Where are Reneo Pharmaceuticals offices?

    Reneo Pharmaceuticals has an office in San Diego.

  • How many offices does Reneo Pharmaceuticals have?

    Reneo Pharmaceuticals has 1 office.